Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Tianyin Pharmaceutical, a pharmaceutical company, has initiated its Qionglai Facility (QLF) project following the initial planning period.
Subscribe to our email newsletter
The Phase I of QLF project will be the construction of the pre-extraction plant which is ecpected to get completed by the end of 2012.
The new pre-extraction facility will conduct initial processing of TCM raw material, separation using alcohol or water precipitation, filtration, centrifugation, concentration and purification of TCM pharmaceutical ingredients.
TPI’s manufacturing facility at the Longquan district, east of Chengdu, designated for automotive industry, is scheduled to be relocated to Qionglai city, south of Chengdu, designated for pharmaceutical industry.
The proposed relocation project also includes TCM pre-extraction plant which is located near the center of the city of Chengdu.
The QLF is estimated to be 80 mu or 53,000m2. Both pre-extraction plant and the formulation plant are to be relocated, the company said.
The re-location and construction cost is estimated at $25m for Phase I which will expand the current capacity by 30%.
For Phase II QLF, an additional $10 million may be employed to double the current capacity by 2013.